Published in Blood on December 01, 1976
Humoral factor that specifically regulates prothrombin (factor II) levels (coagulopoietin-II). Proc Natl Acad Sci U S A (1979) 0.85
Humoral factor that specifically regulates factor X levels in rabbits (coagulopoietin-X). J Clin Invest (1979) 0.75
Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med (1982) 2.57
Should all pregnant women be tested for their platelet PLA (Zw, HPA-1) phenotype? Br J Haematol (1994) 2.06
The effect of azidothymidine on HIV-related thrombocytopenia. N Engl J Med (1988) 1.98
Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest (1969) 1.93
Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost (2001) 1.93
Autoimmune thrombocytopenic purpura. Blood (1980) 1.92
Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest (1969) 1.88
On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med (1984) 1.87
Autoimmune thrombocytopenic purpura. Semin Hematol (1985) 1.74
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost (2003) 1.55
Role of platelets in tumor cell metastases. Ann Intern Med (1981) 1.46
Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood (1998) 1.42
Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis. J Clin Invest (1967) 1.41
Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res (1992) 1.38
Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood (1978) 1.37
Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest (1991) 1.36
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35
Use of the megathrombocyte as an index of megakaryocyte number. N Engl J Med (1971) 1.35
Preservation of functioning human thyroid organoids in the scid mouse: 1. System characterization. J Clin Endocrinol Metab (1993) 1.33
Thrombocytopenic purpura in narcotics addicts. Ann Intern Med (1985) 1.33
Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab (1987) 1.29
Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell (2001) 1.26
Biochemical energetics of simulated platelet plug formation. Effect of thrombin, adenosine diphosphate, and epinephrine on intra- and extracellular adenine nucleotide kinetics. J Clin Invest (1968) 1.26
Indirect immunofluorescence assay for antibodies to human immunodeficiency virus. J Clin Microbiol (1987) 1.25
Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost (1995) 1.22
Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.22
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A (1997) 1.21
A solid-phase radioimmunoassay for bound anti-platelet antibody: studies on 45 patients with autoimmune platelet disorders. J Lab Clin Med (1979) 1.16
Antiplatelet treatment of thrombotic thrombocytopenic purpura. Ann Intern Med (1977) 1.14
Biochemical and biophysical aspects of human platelet adhesion to collagen fibers. J Clin Invest (1971) 1.14
Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Cancer Res (1984) 1.14
Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol (1997) 1.08
Role of platelets in tumor cell metastases. Ann N Y Acad Sci (1981) 1.05
Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood (2000) 1.04
Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem (2000) 1.03
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci U S A (1980) 1.03
Crossed immunoelectrophoresis of human platelet membranes. The major antigen consists of a complex of glycoproteins, GPIIb and GPIIIa, held together by Ca2+ and missing in Glanzmann's thrombasthenia. J Biol Chem (1982) 1.03
Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med (1972) 1.03
Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. J Clin Invest (1986) 1.02
Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer (1993) 1.01
Risks of using platelet rich plasma gel. J Oral Maxillofac Surg (1998) 1.00
Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med (1981) 0.99
Presence of a nonsplenic platelet pool. Blood (1977) 0.99
Thrombocytopenia in the high-risk infant. J Pediatr (1980) 0.99
A new mechanism for tumor induced platelet aggregation. Comparison with mechanisms shared by other tumor with possible pharmacologic strategy toward prevention of metastases. Int J Cancer (1983) 0.97
Crossed immunoelectrophoresis of human platelet membranes. Diminished major antigen in Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Biol Chem (1980) 0.96
Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood (1998) 0.96
Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients. Ann Intern Med (1974) 0.95
Mendelian diseases among Roman Jews: implications for the origins of disease alleles. J Clin Endocrinol Metab (1999) 0.95
Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol (1972) 0.95
Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol (1996) 0.95
A monoclonal anti-platelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets. Proc Natl Acad Sci U S A (1983) 0.95
Heterogeneity of human platelets. Metabolic and kinetic evidence suggestive of young and old platelets. Ser Haematol (1971) 0.94
Lack of effect of in vivo prostacyclin on the development of pulmonary metastases in mice following intravenous injection of CT26 colon carcinoma, Lewis lung carcinoma, or B16 amelanotic melanoma cells. Cancer Res (1984) 0.94
Preservation of the parathyroid glands in total thyroidectomy. Surg Gynecol Obstet (1987) 0.93
Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. Blood (1993) 0.93
Heterogeneity of human fibrinogen: possible relation to proteolysis by thrombin and plasmin as studies by SDS-polyacrylamide gel electrophoresis. Biochem Biophys Res Commun (1970) 0.92
Platelet counts in infants of women with autoimmune thrombocytopenia: effects of steroid administration to the mother. N Engl J Med (1981) 0.92
Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med (1988) 0.91
Requirement of iron for platelet protein synthesis. Biochem Biophys Res Commun (1973) 0.91
Trace elements in noraml and malignant human breast tissue. Surgery (1974) 0.91
The megathrombocyte as an index of platelet production. Br J Haematol (1974) 0.91
Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187. J Clin Invest (1980) 0.91
On the "easy bruising" syndrome with normal platelet count. A study of 75 patients. Ann Intern Med (1975) 0.91
Heterogeneity of platelet function. Correlation with platelet volume. Am J Med (1978) 0.90
Evidence for a humoral agent capable of raising vitamin-K-dependent coagulation factors in rabbits. Br J Haematol (1973) 0.90
Prothrombin and protein C in early childhood: normal adult levels are not achieved until the fourth year of life. J Pediatr (1986) 0.89
Idiopathic thrombocytopenic purpura in homosexual men. Ann N Y Acad Sci (1984) 0.89
Purpura fulminans caused by group A beta-hemolytic Streptococcus sepsis. J Pediatr (2000) 0.89
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. Cancer Res (1981) 0.89
Osteogenic sarcoma arising in a preexisting fibrous dysplasia: report of case. J Oral Surg (1971) 0.89
Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance. J Pediatr (1981) 0.89
Autoimmune thrombocytopenic purpura and the compensated thrombocytolytic state. Am J Med (1971) 0.88
Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J Exp Med (2000) 0.88
Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost (2001) 0.88
Hetrogeneity of human platelets. 3. Glycogen metabolism in platelets of different sizes. Br J Haematol (1970) 0.87
The increased percentage of megathrombocytes in various clinical disorders. Ann Intern Med (1972) 0.87
Elevated platelet count and megathrombocyte number in sickle cell anemia. Blood (1975) 0.86
Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease. Autoimmunity (1990) 0.86
Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol (1999) 0.86
Deficiency of glutathione peroxidase associated with high levels of reduced glutathione in glanzmann's thrombasthenia. N Engl J Med (1972) 0.86
Studies of the origin of platelet-associated fibrinogen. J Lab Clin Med (1984) 0.85
Association of HLA-DRw2 with autoimmune thrombocytopenic purpura. J Clin Invest (1979) 0.85
Identification of a family of alternatively spliced mRNA species of angiopoietin-1. Blood (2000) 0.85
The initial macromolecular derivatives of human fibrinogen produced by plasmin. Biochim Biophys Acta (1972) 0.85
Humoral factor that specifically regulates prothrombin (factor II) levels (coagulopoietin-II). Proc Natl Acad Sci U S A (1979) 0.85
Cooley anemia: high transfusion regimen and chelation therapy, results, and perspective. J Pediatr (1978) 0.84
CT in B-thalassemia: iron deposition in the liver, spleen, and lymph nodes. AJR Am J Roentgenol (1981) 0.84
An epidemic of maternal thrombocytopenia associated with elevated antiplatelet antibody. Platelet count and antiplatelet antibody in 116 consecutive pregnancies: relationship to neonatal platelet count. Am J Obstet Gynecol (1986) 0.84
Extraction and characterization of a platelet-aggregating material from SV40-transformed mouse 3T3 fibroblasts. J Lab Clin Med (1979) 0.84
Disseminated intravascular coagulation following cardiac arrest: a study of 15 patients. Am J Med Sci (1972) 0.84
Effect of insulin and muscle contraction on protein synthesis in frog sartorius. Arch Biochem Biophys (1967) 0.83